CAI
MRK icon

Capital Advisors Inc’s Merck MRK Stock Holding History

Capital Advisors Inc’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Buy
9,821
+46
+0.5% +$5.38K 0.02% 156
2026
Q1 		$1.18M Sell
9,775
-183
-2% -$21.1K 0.02% 154
2025
Q4 		$1.05M Buy
9,958
+844
+9% +$79.2K 0.02% 158
2025
Q3 		$765K Buy
9,114
+2,806
+44% +$231K 0.01% 169
2025
Q2 		$499K Sell
6,308
-484
-7% -$38.5K 0.01% 199
2025
Q1 		$610K Sell
6,792
-561
-8% -$52.4K 0.01% 179
2024
Q4 		$732K Sell
7,353
-35
-0.5% -$3.61K 0.01% 161
2024
Q3 		$839K Sell
7,388
-128
-2% -$15.2K 0.02% 158
2024
Q2 		$930K Buy
7,516
+201
+3% +$25.9K 0.02% 152
2024
Q1 		$965K Buy
7,315
+315
+5% +$38.8K 0.02% 150
2023
Q4 		$763K Sell
7,000
-107
-2% -$11.1K 0.02% 172
2023
Q3 		$732K Sell
7,107
-41
-0.6% -$4.42K 0.02% 150
2023
Q2 		$825K Buy
7,148
+475
+7% +$53.9K 0.02% 150
2023
Q1 		$710K Sell
6,673
-949
-12% -$102K 0.02% 153
2022
Q4 		$846K Sell
7,622
-61
-0.8% -$6.24K 0.02% 149
2022
Q3 		$708K Sell
7,683
-117
-2% -$10.4K 0.02% 149
2022
Q2 		$711K Sell
7,800
-961
-11% -$85.2K 0.02% 153
2022
Q1 		$719K Sell
8,761
-1,436
-14% -$113K 0.02% 149
2021
Q4 		$781K Buy
10,197
+3,508
+52% +$279K 0.02% 141
2021
Q3 		$502K Sell
6,689
-6
-0.1% -$456 0.01% 165
2021
Q2 		$521K Sell
6,695
-643
-9% -$47.8K 0.02% 163
2021
Q1 		$540K Buy
7,338
+496
+7% +$36.6K 0.02% 151
2020
Q4 		$534K Buy
6,842
+389
+6% +$29.8K 0.02% 134
2020
Q3 		$511K Buy
6,453
+248
+4% +$19.4K 0.02% 130
2020
Q2 		$480K Buy
6,205
+224
+4% +$16.9K 0.02% 128
2020
Q1 		$439K Buy
5,981
+135
+2% +$10.6K 0.02% 117
2019
Q4 		$507K Sell
5,846
-1,660
-22% -$136K 0.02% 131
2019
Q3 		$601K Hold
7,506
– – 0.03% 126
2019
Q2 		$601K Buy
+7,506
New +$575K 0.03% 126
2019
Q1 		– Sell
-186,199
Closed -$13.6M – 166
2018
Q4 		$13.6M Buy
186,199
+12,798
+7% +$903K 0.88% 30
2018
Q3 		$11.7M Buy
173,401
+1,908
+1% +$122K 0.7% 46
2018
Q2 		$9.93M Sell
171,493
-3,443
-2% -$194K 0.6% 54
2018
Q1 		$9.09M Buy
174,936
+5,938
+4% +$321K 0.55% 60
2017
Q4 		$9.07M Sell
168,998
-36,271
-18% -$2.01M 0.53% 64
2017
Q3 		$12.5M Buy
205,269
+12,575
+7% +$762K 0.77% 41
2017
Q2 		$11.8M Buy
192,694
+380
+0.2% +$23.1K 0.73% 49
2017
Q1 		$11.7M Buy
192,314
+3,071
+2% +$186K 0.76% 46
2016
Q4 		$10.6M Buy
189,243
+10,457
+6% +$612K 0.74% 42
2016
Q3 		$10.6M Buy
178,786
+381
+0.2% +$22.3K 1.59% 22
2016
Q2 		$9.81M Buy
178,405
+8,048
+5% +$428K 1.52% 26
2016
Q1 		$8.6M Buy
170,357
+463
+0.3% +$22.7K 1.41% 31
2015
Q4 		$8.56M Buy
169,894
+1,947
+1% +$98.2K 1.5% 27
2015
Q3 		$7.91M Buy
+167,947
New +$8.92M 1.43% 32

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Capital Advisors Inc's MRK Position: Q2 2026 in Review

Capital Advisors Inc increased its Merck (MRK) stake by 0.47% in Q2 2026, buying an estimated $5.38K and bringing the position to 9,821 shares worth $1.26M. The position accounts for 0.02% of the portfolio, ranked #156.

Capital Advisors Inc first reported a position in MRK in Q3 2015 and has held it in 43 quarters since. The position peaked at $13.6M in Q4 2018. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Capital Advisors Inc held 9,821 shares of Merck worth $1.26M as of Q2 2026.
  • Capital Advisors Inc bought 46 Merck shares in Q2 2026, an estimated $5.38K.
  • Merck made up 0.02% of Capital Advisors Inc's portfolio in Q2 2026, its #156 holding.
  • Capital Advisors Inc first reported a position in Merck in Q3 2015 and has held it in 43 quarters since.
  • Capital Advisors Inc's Merck position peaked at $13.6M in Q4 2018.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.